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Heligmosomoides polygyrus bakeri is a model parasitic hookworm used to study animal and human hel-
minth diseases. During infection, the parasite releases excretory/secretory products that modulate the
immune system of the host. The most abundant protein family in excretory/secretory products comprises
the venom allergen-like proteins (VALs), which are members of the SCP/TAPS (sperm-coating protein/
Tpx/antigen 5/pathogenesis related-1/Sc7) superfamily. There are >30 secreted Heligmosomoides poly-
gyrus VAL proteins (HpVALs) and these proteins are characterised by having either one or two 15 kDa
CAP (cysteine-rich secretory protein (CRISP)/antigen 5/pathogenesis related-1) domains. The first known
HpVAL structure, HpVAL-4, refined to 1.9 Å is reported. HpVAL-4 was produced as a homogeneously gly-
cosylated protein in leaves of Nicotiana benthamiana infiltrated with recombinant plasmids, making this
plant expression platform amenable for the production of biological products. The overall topology of
HpVAL-4 is a three layered aba sandwich between a short N-terminal loop and a C-terminal cysteine rich
extension. The C-terminal cysteine rich extension has two strands stabilized by two disulfide bonds and
superposes well with the previously reported extension from the human hookworm Necator americanus
Ancylostoma secreted protein-2 (Na-ASP-2). The N-terminal loop is connected to alpha helix 2 via a disul-
fide bond previously observed in Na-ASP-2. HpVAL-4 has a central cavity that is more similar to the N-
terminal CAP domain of the two CAP Na-ASP-1 from Necator americanus. Unlike Na-ASP-2, mammalian
CRISP, and the C-terminal CAP domain of Na-ASP-1, the large central cavity of HpVAL-4 lacks the two his-
tidines required to coordinate divalent cations. HpVAL-4 has both palmitate-binding and sterol-binding
cavities and is able to complement the in vivo sterol export phenotype of yeast mutants lacking their
endogenous CAP proteins. More studies are required to determine endogenous binding partners of
HpVAL-4 and unravel the possible impact of sterol binding on immune-modulatory functions.
 2018 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology. This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Heligmosomoides polygyrus bakeri is a rodent intestinal nema-
tode that is closely related to ruminant and human hookworm par-
asites. Heligmosomoides polygyrus is able to survive long-term in
the murine host, and is in widespread use as a model for chronic
nematode infections (Behnke, 1987; Robinson et al., 1989). More
importantly, H. polygyrus has been used as a model to study
immunological processes involved in chronic parasitic nematodeinfections and to characterise host-parasite relationships for over
three decades (Behnke, 1987; Robinson et al., 1989; Behnke
et al., 2009; Reynolds et al., 2012; Harris et al., 2014). Heligmoso-
moides polygyrus is retained in the intestine and elicits strong sys-
temic Th2 cell responses (Svetic et al., 1993; Wahid et al., 1994). It
was also determined that H. polygyrus infection drives expansion of
regulatory T cells which are able to suppress allergic airway
inflammation in mouse models of allergic inflammation (Finney
et al., 2007; Rausch et al., 2008; Smith et al., 2016).
H. polygyrus secretes immune-modulatory factors and effectors
that may account for both immune evasion and suppression evi-
dent during infection. Many of the immunomodulatory molecules
are released as parasite excretory/secretory (ES) products
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Passive immunisation with antisera to these ES products confers
50–75% protection against challenge infection (Hewitson et al.,
2009). Due to their immunomodulatory properties, ES products
from H. polygyrus have been explored as putative therapeutic
agents for autoimmune and allergic diseases (Harris et al., 2014).
Similarly, ES products have been studied as candidate vaccine anti-
gens for hookworm infection and schistosomiasis (Verjovski-
Almeida et al., 2003; Bethony et al., 2005; Fujiwara et al., 2005).
Proteomic analysis of ES products of adult H. polygyrus revealed
that the most abundant proteins are members of the venom
allergen-like protein (VAL) family, and among the major ones is
H. polygyrus VAL-4 (HpVAL-4) (Hewitson et al., 2011b). It was pre-
viously shown that homologues of VALs known as Ancylostoma
secreted proteins (ASPs) are the predominant molecules secreted
by canine and human hookworms (Cantacessi et al., 2010; Wang
et al., 2010b). The immunomodulatory functions of ASPs are well
characterised and some are being explored as vaccines and adju-
vants (Fujiwara et al., 2005; He et al., 2009; Gonzalez-Hernandez
et al., 2016). VALs are members of the superfamily that is known
as CAP (cysteine-rich secretory protein/antigen 5/pathogenesis
related-1) or SCP/TAPS (Sperm-coating protein/Tpx/antigen
5/pathogenesis related-1/Sc7). The CAP domain (Pfam PF00188)
has been implicated in conditions requiring cellular defense or pro-
liferation including plant responses to pathogens and human brain
tumour growth (Hawdon et al., 1999; Ding et al., 2000; Gao et al.,
2001; Zhan et al., 2003; Gibbs et al., 2008). In the case of parasite-
encoded CAP proteins, many are considered to fulfil immune mod-
ulatory functions to sustain survival in the host, and for the same
reason are attractive targets for vaccine-induced anti-parasite
immunity (Cantacessi et al., 2009).
There are over 30 secreted HpVALs which dominate the
immune response in H. polygyrus infected mice (Hewitson et al.,
2011b). As observed in human and canine hookworms, HpVALs
are characterised by having either a single or double 15–25 kDa
CAP domain. In infected mice, the antibody response primarily tar-
gets four HpVALs, the double-domain HpVAL-1, -2 and -3, and the
single domain HpVAL-4. Following secondary infection of mice,
antibodies are directed at the same four HpVALs as well as another
single domain family member, HpVAL-7. Both HpVAL-1 and
HpVAL-2 bear an immunodominant O-linked glycan which is
exposed on the parasite surface (Hewitson et al., 2011a). Interest-
ingly, each member of the HpVAL family has a distinct pattern of
expression during the parasite life cycle with HpVAL-4 being
expressed at high levels by all mammalian stages from day 3 and
day 5p.i, L3s, L4s, and adult worms (Hewitson et al., 2013)
Several structures of proteins having a single CAP domain and
one structure of a hookworm ASP with two CAP domains have been
reported (Fernandez et al., 1997; Serrano et al., 2004; Asojo et al.,
2005; Guo et al., 2005; Shikamoto et al., 2005; Wang et al., 2005;
Gibbs et al., 2008; Asojo, 2011; Xu et al., 2012; Borloo et al.,
2013). Each CAP domain has a large central cavity (Serrano et al.,
2004; Asojo et al., 2005, 2011; Gibbs et al., 2008; Suzuki et al.,
2008; Wang et al., 2010a; van Galen et al., 2012; Xu et al., 2012;
Mason et al., 2014; Darwiche et al., 2016; Baroni et al., 2017).
The function of the cavity is unknown but in some SCP/TAPs pro-
teins the cavity contains two histidine residues that have been
shown to bind divalent cations including Zn2+ and Mg2+ (Gibbs
and O’Bryan, 2007; Gibbs et al., 2008). The ability to bind Zn2+ is
critical for heparin-sulphate dependent inflammatory mechanisms
of the cobra SCP/TAPs protein natrin (Wang et al., 2010a).
The central CAP domain has a conserved alpha–beta–alpha
sandwich topology with variations in the lengths of their strands
and helices as well as the lengths, orientations, and locations of
loops (Asojo, 2011). These long flexible loops make up as much
as 50% of the overall structure of the CAP domain, making itdifficult to accurately predict or model their structures (Asojo
et al., 2005; Asojo, 2011; Darwiche et al., 2016; Baroni et al.,
2017). Interestingly, one of the flexible loop regions of the CAP
domain was identified as the sterol-binding caveolin-binding motif
(CBM) of yeast CAP proteins required for in vivo cholesterol trans-
port (Choudhary et al., 2014; Darwiche et al., 2016). Two additional
lipid-binding regions have been identified in CAP proteins, and all
three lipid-binding regions are unique and unconnected in all
reported monomer structures of CAP domains (Fernandez et al.,
1997; Hawdon et al., 1999; Ding et al., 2000; Gao et al., 2001,
2005; Zhan et al., 2003; Serrano et al., 2004; Asojo et al., 2005;
Shikamoto et al., 2005; Wang et al., 2005; Gibbs et al., 2008;
Asojo, 2011; Xu et al., 2012; Borloo et al., 2013). The second
lipid-binding region is a large hydrophobic cavity between two
helices that was identified in horsefly tablysin-15. Tablysin-15
binds leukotrienes in this cavity and functions as an anti-
inflammatory scavenger of eicosanoids (Xu et al., 2012). In
addition, the yeast CAP protein Pry1 is structurally able to accom-
modate lipids such as palmitate, and it binds and exports fatty
acids similarly to tablysin-15 (Darwiche et al., 2016). The third
lipid-binding motif has only been reported on the surface of
human Golgi-associated PR-1 protein (GLIPR2) and facilitates the
binding of up to three phosphatidylinositol molecules (van Galen
et al., 2010, 2012). These structural and functional insights into
the SCP/TAPS proteins from many different organisms prompted
us to analyse a predominant homologue secreted into H. polygyrus
ES products, HpVAL-4, and we present here the X-ray structure and
functional role of HpVAL-4 in cholesterol transport.2. Materials and methods
2.1. Plant-based expression of HpVAL-4
The complete sequence encoding mature HpVAL-4 was codon
optimised in–house and synthetically constructed at GeneArt. This
sequence was cloned into a pHYG expression vector and was pre-
ceded by the Arabidopsis thaliana chitinase signal peptide (cSP). The
HpVAL-4 expression vector was used to transform Agrobacterium
tumefaciens (strain MOG101) and used for agro-infiltration. To
enhance expression, the plasmid vector pBIN61 containing the
silencing inhibitor p19 from tomato bushy stunt virus was co-
infiltrated. HpVAL-4 and p19 Agrobacterium tumefaciens clones
were grown in Lennox broth (10 g/L of peptone140, 5 g/L of yeast
extract, 10 g/L of NaCl pH 7.0) containing 50 lg/ml of kanamycin
and 20 lM acetosyringone for 16 h at 28 C/250 rpm. For
agro-infiltration of HpVAL-4 and p19, MMA infiltration medium
(20 g/L of sucrose, 5 g/L of Murashige and Skoog basal salt mixture,
1.95 g/L of (N-morpholino)ethanesulfonic acid pH5.6) containing
200 lM acetosyringone was used to suspend the bacterial cultures
to a final O.D. of 0.5 per culture. A 1 ml needleless syringe was used
to infiltrate the Agrobacterium suspension into the youngest fully
expanded leaves of 5–6 weeks old Nicotiana benthamiana plants
at the abaxial side. Nicotiana benthamiana plants were maintained
in a controlled greenhouse compartment (UNIFARM, Wageningen,
Netherlands) and infiltrated leaves were harvested at 5–6 days
post infiltration.2.2. Purification of HpVAL-4
HpVAL-4 was purified from the leaf extracellular space
(apoplast) as described previously (Wilbers et al., 2017). Briefly,
the infiltrated leaves were submerged in ice-cold extraction buffer
(20 mM sodium citrate pH 3.6, 100 mM NaCl and 0.1% v/v
Tween-20). The submerged leaves were vacuum infiltrated and
the apoplast fluid was retrieved by centrifugation for 10 min at
Table 1
Data collection and refinement statistics for Heligmosomoides polygyrus Venom
Allergen-like Protein-4 (HpVAL-4).
Data collection HpVAL-4
Wavelength 0.15418 nm
Resolution range (Å) 40.88–1.99 (2.061–1.99)
Space group P1
Unit cell a = 49.5596 Å b = 61.5645 Å c = 74.8188 Å
a = 111.595 b = 90.14 c = 113.475o
Total reflections 351,786 (23932)
Unique reflections 48,534 (4696)
Multiplicity 7.2 (7.3)
Completeness (%) 95.36 (92.93)
Mean I/sigma (I) 18 (11.3)
Wilson B-factor 16.45
R-merge 0.139 (0.700)
R-meas 0.156 (0.762)
R-pim 0.084 (0.421)
CC1/2 0.996 (0.961)
Reflections used in refinement 48,531 (4696)
Reflections used for R-free 2462 (225)
R-work 0.1748 (0.1824)
R-free 0.2231 (0.2702)
Number of non-hydrogen atoms 6464
Macromolecules 5921
Ligands 180
Solvent 363
Protein residues 749
RMS (bonds) 0.009 Å
RMS (angles) 1.39o
Ramachandran favoured (%) 97.71
Ramachandran allowed (%) 2.29
Ramachandran outliers (%) 0.00
Rotamer outliers (%) 0.15
Clashscore 4.05
Average B-factor 17.84
Macromolecules 17.50
Ligands 25.31
Solvent 19.72
Statistics for the highest resolution shell are shown in parentheses.
RMSD, root-mean-square deviation; CC, correlation coefficient.
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at 16,000 g. HpVAL-4 was then purified from the apoplast fluid
using HS POROS 50 strong cation exchange (CEX) resin (Applied
Biosystems, USA). Prior to purification the apoplast fluid was
passed over a G25 Sephadex column with CEX binding buffer
(20 mM sodium citrate buffer pH 3.6, 100 mM NaCl). HpVAL-4
bound to CEX resin was eluted with 20 mM Tris–HCl buffer pH
9.0 containing 2 M NaCl. The purification was performed on an
ÄKTA Prime Chromatography System (GE Healthcare, USA) using
a constant flow rate of 10 mL/min for binding and washing, and
2 mL/min for elution. Eluted HpVAL-4 was dialyzed overnight in
PBS. Recombinant HpVAL-4 was separated under reduced condi-
tions by SDS–PAGE on a 12% Bis-Tris gel (Invitrogen, USA) and sub-
sequently stained with Coomassie brilliant blue staining.
2.3. Analysis of N-glycan composition
For N-glycan analysis, 1–2 lg of purified HpVAL-4 was reduced
and denatured for 10 min at 95 C in PBS containing 1.3% (w/v) SDS
and 0.1% (v/v) b-mercaptoethanol. SDS was neutralised by adding
2% (v/v) NP-40 prior to overnight digestion at 37 C with trypsin
(Sigma–Aldrich, USA) immobilised to N-hydroxysuccinimide-
activated Sepharose (GE Healthcare). Trypsin beads were removed
from the digestion mix by centrifugation and the pH of the mix was
adjusted to 5 using 1 M sodium acetate. PNGase A (0.5 mU; Roche,
Switzerland) was used to release N-glycans from HpVAL-4 while
incubating overnight at 37 C. The incubation mixture was applied
to C18 BakerbondTM SPE cartridges (JT Baker, USA) and the N-
glycans were extracted from the flow-through on Extract CleanTM
Carbo SPE columns. Eluted N-glycans were labelled with anthrani-
lic acid (Sigma–Aldrich) and desalted by hydrophilic interaction
chromatography on Biogel P10 (BioRad). Samples in 75%
acetonitrile were mixed with 1 ll of matrix solution (20 mg/ml
of 2,5-dihydroxybenzoic acid in 50% acetonitrile, 0.1% (v/v)
trifluoroacetic) and were dried under a stream of warm air.
Matrix-assisted laser desorption/ionisation (MALDI) time-of-flight
mass spectra (MS) were obtained using an Ultraflex II mass
spectrometer (Bruker Daltonics, USA).
2.4. Crystallisation
HpVAL-4 (10 mg/ml) in PBS was screened for crystallisation
conditions with commercial screens from Qiagen (Germany),
Hampton Research (USA) and Microlytics (USA). Crystals were
obtained from multiple conditions with polyethylene glycol, and
the best diffracting crystals were obtained at 298 K by vapour dif-
fusion in sitting drops by mixing 1.5 ll of protein solution with an
equal volume of the reservoir solution containing 0.1 M sodium
acetate trihydrate at pH 4.5, 22.5% (w/v) polyethylene glycol
0.3–8 kD. Since the crystals grew in solutions that contained
adequate cryo-protectant, all crystals were flash-cooled directly
in a stream of N2 gas at 113 K prior to collecting diffraction data.
2.5. Data collection and structure determination
X-ray diffraction data were collected at the Baylor College of
Medicine, USA, core facility using a Rigaku HTC detector. The X-
ray source was a Rigaku FR-E + SuperBright microfocus rotating
anode generator with VariMax HF optics. A data set was collected
from a single crystal with a crystal-to-detector distance of 105 mm
and exposure times of 120 s for 0.5 oscillations, using the Crystal
Clear (d⁄trek) package (Pflugrath, 1999). Data was processed using
MosFLM (Leslie, 2006). The crystal belonged to the triclinic space
group P1 with cell constants a = 49.5596 Å b = 61.5645 Å c = 74.81
88 Å, a = 111.595 b = 90.14 c = 113.475.Similar to previous CAP structures, HpVAL-4 structure was
solved after several attempts at molecular replacement (MR) using
different search models (Asojo et al., 2005; Asojo, 2011) with PHA-
SER (Storoni et al., 2004; McCoy et al., 2005). Using Na-ASP-2 as the
search model, a solution was obtained and the model was
improved through automatic model building with ARP/wARP
(Morris et al., 2003, 2004) followed by manual model building
cycles using the programme Coot (Emsley et al., 2010) and struc-
ture refinement with REFMAC5 (Murshudov et al., 2011) within
the CCP4 package (Winn et al., 2011) and Phenix (Terwilliger
et al., 2008; Adams et al., 2010). The resulting model was com-
prised of amino acid residues, glycans, and water molecules. No
electron density was observed that could be modelled as any lipids
usurped during recombinant protein production. Ribbon diagram
and model figures were generated using PyMOL (www.pymol.
org). Details of the quality of the structure as well as data collection
are shown in Table 1. The atomic coordinate and structure factors
have been deposited in the protein databank (www.rcsb.org) under
accession number 5WEE.
2.6. Size exclusion chromatography and multi-angle light scattering
(SEC-MALS)
SEC-MALS experiments were performed by loading 10 lg of
protein sample onto a Phenomenex Yarra 3 mm SEC-2000 column
(Phenomenex, Torrance, CA, USA) at a flow-rate of 0.5 ml/min
using an Agilent 1260 Infinity series HPLC. The mobile phase was
PBS buffer at pH 7.4. The elution was detected with a UV detector
(Agilent, USA a miniDAWN triple-angle light-scattering detector
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refractometer (Wyatt Technology) connected in series. The isotro-
pic scatterer for detector normalisation was bovine serum albu-
min. Since the light scattered by a protein is directly proportional
to its weight-average molecular mass and concentration, molecu-
lar masses were calculated from the light-scattering and interfero-
metric refractometer data using ASTRA 6.1 software.
2.7. In vivo sterol export from mutant yeast cells
Acetylation and export of sterols into the culture supernatant
was examined as previously described (Tiwari et al., 2007). Heme
(hem1D) -deficient yeast cells were cultivated in presence of
Cholesterol/Tween 80 containing media and labelled with 0.025
mCi/ml [14C] cholesterol (American Radiolabeled Chemicals Inc,
St. Louis, MO, USA). Cells were harvested by centrifugation, washed
twice with synthetic complete (SC) media, diluted to an O.D.600 of 1
into fresh SC media containing non-radiolabeled cholesterol and
grown overnight. Cells were centrifuged and lipids were extracted
from the cell pellet and the culture supernatant using chloroform/
methanol (v/v 1:1). Samples were dried and separated by thin-
layer chromatography (TLC) using silica gel 60 plates (Merck,
Darmstadt, Germany) using the solvent system, petroleum ether/
diethyl ether/acetic acid (70:30:2; per vol.). Radiolabeled lipids
on the TLC were quantified by scanning with a Berthold Tracemas-
ter 40 Automatic TLC-Linear Analyzer (Berthold Technologies, Bad
Wildbad, Germany). TLC plates were then exposed to phosphorim-
ager screens and radiolabeled lipids were visualised using a phos-
phorimager (Bio-Rad Laboratories, Hercules, CA, USA).
2.8. In vitro sterol binding
In vitro sterol binding was assessed using a previously
described radioligand-binding assay (Im et al., 2005; Choudhary
and Schneiter, 2012; Darwiche and Schneiter, 2017). Briefly, 100
pmol of purified protein in binding buffer (20 mM Tris, pH 7.5,
30 mM NaCl, 0.05% Triton X-100) were incubated with 0–400 pmol
of [3H]-cholesterol (American Radiolabeled Chemicals Inc., St Louis,
Missouri, USA) for 1 h at 30 C. The protein was adsorbed to Q-
Sepharose beads (GE healthcare) to remove unbound ligand, the
beads were washed, and the radioligand was quantified by scintil-
lation counting. For competition assays, 400 pmol of unlabeled
cholesterol were included in the binding reaction, together with
the indicated concentrations of [3H]-cholesterol. To determine
non-specific binding, the ion exchange beads were incubated in
the absence of added protein. At least two independent experi-
ments were performed under each experimental condition and
data are reported as the mean ± S.D. Calculation of the Kd value
and curve fitting were performed using the statistical software
Prism (GraphPad, La Jolla, CA, USA).3. Results
3.1. Recombinant HpVAL-4
Expression of HpVAL-4 in our plant-based expression system
resulted in a yield of 0.5–1.0 mg of pure recombinant protein per
plant (3–4 g of leaf material). Recombinant HpVAL-4 was shown
to be 95% pure by a Coomassie stained SDS–PAGE gel (Fig. 1A).
The oligomeric state of recombinant HpVAL-4 in solution was
determined by measuring the absolute molecular mass by SEC-
MALS. The protein gave a single peak on the sizing column
(Fig. 1B) with a molecular mass of 21.07 ± 0.66 kDa, consistent
with its theoretical molecular mass of 21.7 kDa, indicating that
HpVAL-4 forms a monomer in solution. It had been previouslyspeculated that dimerisation was important for the functions of
SCP/TAPS proteins (Asojo et al., 2005; Gibbs et al., 2008). Our ongo-
ing studies reveal that while some SCP/TAPS proteins such as
MpPR-1i and SmVAL-4 form monomers in solution (Kelleher
et al., 2015; Baroni et al., 2017), others including GAPR-1, Na-
ASP-2 and GLIPR-1 form dimers in solution (Asojo et al., 2005;
Gibbs et al., 2008).
The glycosylation composition of HpVAL-4 was then assessed
by MALDI-TOF MS analysis of released N-glycans. All N-glycan
types found on the HpVAL-4 protein carry typical plant beta(1,2)-
xylose and core alpha(1,3)-fucose residues (Fig. 1C). Furthermore,
the majority of the N-glycans are biantennary with terminal
GlcNAc residues (GnGnXF3), but also paucimannosidic N-glycans
(MMXF3) and N-glycans with one terminal GlcNAc residue were
detected (MGnXF3 or GnMXF3). These latter structures likely arise
from apoplastic b-hexosaminidase activity (Shin et al., 2017). Alto-
gether, our results demonstrate that plants are well suited as an
expression platform for CAP proteins from helminths.3.2. Crystal structure of HpVAL-4
Each HpVAL-4 monomer folds as an alpha–beta–alpha sand-
wich, in which a beta sheet is sandwiched between two helical/
loop regions (Fig. 2A). This classic SCP/TAPs motif is flanked by
N-terminal and C-terminal extensions that are stabilised by
disulfide bonds. While the refined model has four monomers of
HpVAL-4 in the asymmetric unit (Supplementary Figs. S1 and
S2), this tetramer is likely an artefact of crystallisation as
SEC-MALS analysis indicates that HpVAL-4 is a monomer in solu-
tion. The monomers are very similar with root mean square devia-
tion (rmsd) ranging between 0.075 Å and 0.176 Å for alignment of
main chain atoms. The most variable regions between the mono-
mers are loop regions, except the C-terminal extension that is virtu-
ally identical (Fig. 2B). The predicted N-linked glycosylation site
Asn12 is glycosylated for all fourmonomers (Fig. 2A and B). The sur-
face plot of HpVAL-4 reveals a large central CAP cavity of 1732.64
Å3, which is bordered by the first beta strand (b1) and the third
and fourth alpha helices (a2,a4), and opens into a C-terminal loop
(Fig. 2). This cavity is comparable in size to previously reported
SCP/TAPs protein structures (Asojo et al., 2005, 2011; Gibbs et al.,
2008; Wang et al., 2010a; Asojo, 2011; Ma et al., 2011; Kelleher
et al., 2015). Additionally, within the crystallographic tetramer
there are no possible dimers that have packing similar to either
the two-CAP Na-ASP-1 or the dimer in Pry1 that connect both
central CAP cavities (Asojo, 2011; Darwiche et al., 2016).3.3. HpVAL-4 rescues the cholesterol export defect in pry1D pry2D
mutant cells and binds sterol in vitro
To test whether expression of HpVAL-4 in pry1D pry2D mutant
cells rescued the defect in cholesterol export, heme-deficient cells
containing either an empty plasmid or a plasmid with HpVAL-4
were radiolabeled with [14C]cholesterol overnight, washed and
diluted in fresh media to allow for export of cholesterol and choles-
teryl acetate. Lipids were extracted from the cell pellet (P) and the
culture supernatant (S), and separated by thin layer chromatogra-
phy (Fig. 3A). The levels of free cholesterol and cholesteryl acetate
were quantified by radio scanning and the relative percentages of
cholesteryl acetate exported by the cells were plotted as the export
index which is the ratio between the extracellular cholesteryl acet-
ate and the sum of intra- and extra-cellular cholesteryl acetate
(Fig. 3B). Cells complemented with HpVAL-4 exported cholesteryl
acetate into the culture supernatant at levels comparable to
wild-type cells and Pry1 indicating that HpVAL-4 is an effective
exporter.
Fig. 1. Protein purity and characterisation of Heligmosomoides polygyrus Venom Allergen-like Protein-4 (HpVAL-4). (A) Coomasie-stained SDS gel reveals the purity of
recombinant HpVAL-4 and its monomeric mass of 22 kDa. (B) Size exclusion chromatography multi-angle light scattering analysis reveals that HpVAL-4 is an 21 kDa
monomer in solution. (C) N-glycan composition of plant-produced HpVAL-4.
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direct binding assay in which increasing concentrations of [3H]-
cholesterol (0–400 pmol) were incubated with 100 pmol of
HpVAL-4 proteins. The protein was separated from unbound ligand
by adsorption to an anion-exchange matrix and bound radioligand
was quantified by scintillation counting. HpVAL-4 binds choles-
terol in vitro with a saturable kd of 1.53 lM, which is comparable
to that of Pry1 (kd of 1.25 lM) (Darwiche et al., 2016). Furthermore,
cholesterol binding is specific as addition of unlabeled cholesterol
(400 pmol) competes with radioligand binding (Fig. 3C). These
binding studies show that HpVAL-4 binds [3H]-cholesterol in a
concentration-dependent manner and that binding of the radiola-
beled ligand can be competed with by incubation with unlabeled
cholesterol (Fig. 3C).4. Discussion
Using structural similarity in PDBeFold (http://www.ebi.ac.uk/
msd-srv/ssm/), a three-dimensional (3-D) structural alignment
that takes both the alignment length and rmsd into account, struc-
tures that were most similar to HpVAL-4 were identified as CAPproteins that have less than 30% sequence identity with HpVAL-4.
The most similar structure to HpVAL-4 is that of Na-ASP-2,
(Asojo et al., 2005; Mason et al., 2014) followed by human
hookworm platelet inhibitor, HPI (Ma et al., 2015), Ancylostoma-
secreted protein, Ac-ASP-7 (Osman et al., 2012), Schistosoma man-
soni venom allergen-like protein 4, SmVAL4, (Kelleher et al., 2015),
tablysin-15 (Ma et al., 2011), pry1 (Darwiche et al., 2016), human
GAPR-1 (van Galen et al., 2012) and P14A from tomato
(Fernandez et al., 1997). HpVAL-4 shares a conserved C-terminal
extension with Na-ASP-2 that has two strands, which are stabilised
by two disulfide bonds. This C-terminal extension is more varied in
HPI, SmVAL4 and Ac-ASP-7. The flexible N-terminal loops of both
proteins also have a conserved disulfide bond with alpha helix 2.
Only two proteins with greater than 30% sequence identity with
HpVAL-4 have reported crystal structures, Necator americanus ASP-
1 (Asojo, 2011) and Ostertagia ostertagi ASP-1 (Borloo et al., 2013).
Neither was a top hit based on PDBeFold analysis due to the vari-
ations in the loop regions that make up over 45% of the topology of
CAP proteins. Interestingly, reverse template alignment using Pro-
Func (Laskowski et al., 2005; Laskowski, 2017) reveals that both
structures are certain matches (E-value < 1.00E06) and while
there are indeed insertions and gaps in loop regions, the topology
Fig. 2. Crystal structure of Heligmosomoides polygyrus Venom Allergen-like Protein-4 (HpVAL-4). (A) Cartoon of a monomer of HpVAL-4 rainbow colours from amino (blue) to
carboxyl terminus (red). The two longest helices a1 and a3 that form the palmitate cavity and the caveolin binding motif loop are indicated, while glycans and disulfide
bridges are shown in stick form (coloured by elements: blue for N, white for C, red for O, and yellow for S). (B) Rotation (180 degrees) of the monomer allows better
visualisation of the strand (b1) and helix (a4) that form the central cavity. (C, D) Surface representations of the views for A and B, respectively.
Fig. 3. Heligmosomoides polygyrus Venom Allergen-like Protein-4 (HpVAL-4) exports and binds cholesterol in vivo and in vitro. (A) Expression of HpVAL-4 complements the
sterol export defect of yeast cells lacking their endogenous cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 (CAP) proteins (Pry1 and Pry2). Heme-
deficient cells of the indicated genotype containing either an empty plasmid or a plasmid with Pry1 or HpVAL-4 were radiolabeled with [14C]cholesterol overnight, washed
and diluted in fresh media to allow for export of cholesterol and cholesteryl acetate. Lipids were extracted from the cell pellet (P) and the culture supernatant (S), and
separated by thin layer chromatography. The positions of free cholesterol (FC), cholesteryl acetate (CA) and steryl esters (STE) are indicated. The star marks the position of an
unidentified cholesterol derivative. (B) Quantification of the export of cholesteryl acetate in yeast cells lacking their endogenous CAP proteins when complemented with
empty plasmid, Pry1 or HpVAL-4. The export index indicates the relative percentages of cholesteryl acetate that is exported by the cells (ratio between the extracellular
cholesteryl acetate and the sum of intra- and extra-cellular cholesteryl acetate). Data represent mean ± S.D. of two independent experiments. (C) HpVAL-4 binds cholesterol
in vitro. Purified HpVAL-4 protein (100 pmol) was incubated with the indicated concentration of [3H]-cholesterol in the presence (HpVAL-4 + 400 pmol cholesterol) or
absence of unlabeled competitor ligand (HpVAL-4). The previously determined Pry1 activity is also shown.
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Figs. S3 and S4). As previously mentioned, the loop regions are flex-
ible and varied for SCP/TAPS protein structures and make it diffi-
cult to model the structures. Furthermore, even among those that
share structural similarity with HpVAL-4, the lengths of loops dif-
fer (Fig. 4).
Despite the difference in the orientation of its loop region,
HpVAL-4 has a central exposed cavity similar to previouslyreported SCP/TAPS protein structures (Asojo et al., 2005, 2011;
Gibbs et al., 2008; Asojo, 2011). Since HpVAL-4 lacks the histidines
that bind divalent cations, it is unable to coordinate Zn2+ for the
proposed heparin-sulphate-dependent mechanisms of inflamma-
tory modulation by the cobra CRISP natrin (Wang et al., 2010a).
The sequence of amino acid residues in the CAP cavity of HpVAL-
4 is more similar to that of the N-terminal CAP domain of Na-
ASP-1 (Fig. 4, Supplementary Fig. S4). Comparison of the CAP cavity
Fig. 4. Comparison of Heligmosomoides polygyrus Venom Allergen-like Protein-4 (HpVAL-4) with selected members of its superfamily. The sequences were aligned with
clustalW2 and the secondary structural features were illustrated with the coordinates of HpVAL-4 and Pry1 using ESPript (Gouet et al., 2003). The different secondary
structure elements shown are alpha helices (a), 310-helices (g), beta strands (b), and beta turns (TT). Identical residues are shown in red shading, and conserved residues are
in red text. The locations of the cysteine residues involved in disulfide bonds are numbered in green. The location of the caveolin binding motif loop is shown in blue bars and
the signature cysteine-rich secretory protein (CRISP) motifs are identified with orange bars. The representative structures are Na-ASP-2 (Asojo et al., 2005), Pry1 (Darwiche
et al., 2016), Na-ASP-1 (Asojo, 2011), tablysin-15 (Ma et al., 2011), Golgi-Associated plant Pathogenesis Related protein-1, GAPR-1 (van Galen et al., 2012), Ostertagia ostertagi
activation-associated secreted protein-1, OoASP-1 (Borloo et al., 2013), Ancylostoma caninum Ancylostoma secreted protein-7, Ac-ASP-7 (Osman et al., 2012), Schistosoma
mansoni Venom Allergen-like Protein-4, SmVAL4, (Kelleher et al., 2015), and Solanum lycopersicum pathogenesis-related protein, P14A (Fernandez et al., 1997).
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1 may present a different motif for hookworms and more studies
are needed to identify the biological relevance of the conserved
residues.Fig. 5. Comparison of Heligmosomoides polygyrus Venom Allergen-like Protein-4 (HpVAL-
of HpVAL-4 (cyan) and Pry1 (grey) reveals the conformational flexibility of the caveolin b
The central histidines that coordinate cations in Pry1 are coloured by elements with blue
same view of (B) HpVAL-4 and (C) Pry1. The sizes of the cavities are evident from the s
Fig. 6. The palmitate binding cavity. (A) Ribbon diagram of the putative palmitate-bind
based on (B) the palmitate binding of tablysin-15. Surface representations of same view
shown as yellow sticks and the glycosylation site on HpVAL-4 as other coloured sticks.It was previously shown that Saccharomyces cerevisiae CAP pro-
teins are required for cholesteryl acetate transport (Choudhary and
Schneiter, 2012; Choudhary et al., 2014) and we now report that
HpVAL-4 rescues the sterol-binding function of yeast that lacked4) with pathogen-related yeast protein 1 (Pry1). (A) The superposed ribbon structure
inding motif which contains the 1,2-dioxane from the Pry1 structure (shown in red).
for N, white for C, red for O. Mg2+ is shown as a green sphere. Ribbon diagrams of the
urface plot of the same view of (D) HpVAL-4 and (E) Pry1.
ing cavity of Heligmosomoides polygyrus Venom Allergen-like Protein-4 (HpVAL-4)
of the palmitate binding cavity of (C) HpVAL-4 and (D) tablysin-15, with palmitate
O.A. Asojo et al. / International Journal for Parasitology 48 (2018) 359–369 367the endogenous CAP proteins Pry1 and Pry2, and that recombinant
HpVAL-4 binds sterol in vitro (Fig. 3). While HpVAL-4 has less than
30% sequence similarity to Pry1 and Pry2, it also shares limited
structural similarity with Pry1 (Fig. 4). It has been shown that a
caveolin-binding motif (CBM), which is located in a flexible loop
region connecting helices a3 and a4 (Figs. 2 and 4), that has several
polar amino acid residues capable of interacting with lipids, is
important for both in vivo and in vitro sterol binding by Pry1
(Choudhary et al., 2014). The amino acid sequence of the CBM is
characterised by the presence of conserved aromatic amino acids,
which are required for the in vivo export and the in vitro binding
of sterols in SCP/TAPS proteins. The CBM loop of HpVAL-4 has a dif-
ferent conformation from Pry1 but creates a cavity that is large
enough to accommodate dioxane, as was observed in the structure
of Pry1 (Fig. 5). Interestingly, the insertion of a string of glutamic
acid residues makes the cavity less hydrophobic than observed
for Pry1 (Fig. 4). Our analysis shows that HpVAL-4 has comparable
in vitro cholesterol binding ability to Pry1 (Fig. 3C).
A second distinct and independent lipid-binding function of
SCP/TAPS proteins is the palmitate binding observed in a cavity
between two helices as observed in tablysin-15. This cavity was
also shown to bind leukotriene (Xu et al., 2012). The locations of
alpha helices 1 and 4 are conserved in SCP/TAPS proteins including
HpVAL-4 (Figs. 2 and 4). As previously indicated for other CAP pro-
teins, the amino acid residues in the palmitate binding cavity are
poorly conserved, however there is sufficient space between the
equivalent helices to facilitate palmitate binding (Figs. 2 and 6).
These analyses reveal that HpVAL-4 is structurally able to bind
palmitate, as was observed for tablysin-15. This suggests that
HpVAL4 may be able to bind other fatty acids and fatty acid-
derived products such as the immunologically relevant prostaglan-
dins and leukotrienes. Such a role in immune modulation, rather
than lipid transport within the H. polygyrus organism, is also indi-
cated by its expression across all mammalian stages of the parasite,
and its prominent secretion by both tissue-stage larvae and
luminal-dwelling adults of the species (Hewitson et al., 2013). Fur-
ther studies will shed light on whether HpVAL-4 indeed has such
an immunomodulatory function.
Hp-VAL-4 produced in our plant expression system is a glycosy-
lated protein that readily crystallised from high concentrations of
PEG. HpVAL-4 is a monomer in solution and retains a large open
palmitate-binding cavity, making it capable of binding this and
other lipids. Additionally, the presence of a large CBM explains
the ability of HpVAL-4 to export sterol in vivo. HpVAL-4 has a large
central cavity that lacks the prototypical CAP cavity tetrad, which
means it will be incapable of binding divalent cations. The amino
acid residues in the CAP cavity of HpVAL-4 are more similar to
those in the amino terminal CAP domain of the two CAP Na-ASP-
1. Studies are underway to determine endogenous binding part-
ners of HpVAL-4 and other SCP/TAP proteins from parasites.Acknowledgments
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